Association between uric acid lowering and renal function progression: a longitudinal study

Background This study aimed to explore the association between uric acid lowering and renal function. Materials and Methods We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range...

Full description

Bibliographic Details
Main Authors: Liyi Liu, Lili You, Kan Sun, Feng Li, Yiqin Qi, Chaogang Chen, Chuan Wang, Guojuan Lao, Shengneng Xue, Juying Tang, Na Li, Wanting Feng, Chuan Yang, Mingtong Xu, Yan Li, Li Yan, Meng Ren, Diaozhu Lin
Format: Article
Language:English
Published: PeerJ Inc. 2021-03-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/11073.pdf
id doaj-2c37211f8db74c4d869992301ab8a906
record_format Article
spelling doaj-2c37211f8db74c4d869992301ab8a9062021-03-26T15:05:10ZengPeerJ Inc.PeerJ2167-83592021-03-019e1107310.7717/peerj.11073Association between uric acid lowering and renal function progression: a longitudinal studyLiyi Liu0Lili You1Kan Sun2Feng Li3Yiqin Qi4Chaogang Chen5Chuan Wang6Guojuan Lao7Shengneng Xue8Juying Tang9Na Li10Wanting Feng11Chuan Yang12Mingtong Xu13Yan Li14Li Yan15Meng Ren16Diaozhu Lin17Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Clinical Nutrition, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaBackground This study aimed to explore the association between uric acid lowering and renal function. Materials and Methods We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range of changes in serum uric acid with quartile 1 representing lower quarter. Renal function decline was defined as eGFR decreased more than 10% from baseline in 2016. Renal function improvement was defined as eGFR increased more than 10% from baseline in 2016. Cox regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI). Results In the adjusted Cox regression models, compared to quartile 4, quartile 1 (HR = 0.64, 95% CI [0.49–0.85]), quartile 2 (HR = 0.65, 95% CI [0.50–0.84]) and quartile 3 (HR = 0.75, 95% CI [0.58–0.96]) have reduced risk of renal function decline. An increasing hazard ratio of renal function improvement was shown in quartile 1 (HR = 2.27, 95% CI [1.45–3.57]) and quartile 2 (HR = 1.78, 95% CI [1.17–2.69]) compared with quartile 4. Conclusions Uric acid lowering is associated with changes in renal function. The management of serum uric acid should receive attention in clinical practice and is supposed to be part of the treatment of chronic kidney disease.https://peerj.com/articles/11073.pdfUric acid loweringRenal functionChronic kidney diseasePopulation-based study
collection DOAJ
language English
format Article
sources DOAJ
author Liyi Liu
Lili You
Kan Sun
Feng Li
Yiqin Qi
Chaogang Chen
Chuan Wang
Guojuan Lao
Shengneng Xue
Juying Tang
Na Li
Wanting Feng
Chuan Yang
Mingtong Xu
Yan Li
Li Yan
Meng Ren
Diaozhu Lin
spellingShingle Liyi Liu
Lili You
Kan Sun
Feng Li
Yiqin Qi
Chaogang Chen
Chuan Wang
Guojuan Lao
Shengneng Xue
Juying Tang
Na Li
Wanting Feng
Chuan Yang
Mingtong Xu
Yan Li
Li Yan
Meng Ren
Diaozhu Lin
Association between uric acid lowering and renal function progression: a longitudinal study
PeerJ
Uric acid lowering
Renal function
Chronic kidney disease
Population-based study
author_facet Liyi Liu
Lili You
Kan Sun
Feng Li
Yiqin Qi
Chaogang Chen
Chuan Wang
Guojuan Lao
Shengneng Xue
Juying Tang
Na Li
Wanting Feng
Chuan Yang
Mingtong Xu
Yan Li
Li Yan
Meng Ren
Diaozhu Lin
author_sort Liyi Liu
title Association between uric acid lowering and renal function progression: a longitudinal study
title_short Association between uric acid lowering and renal function progression: a longitudinal study
title_full Association between uric acid lowering and renal function progression: a longitudinal study
title_fullStr Association between uric acid lowering and renal function progression: a longitudinal study
title_full_unstemmed Association between uric acid lowering and renal function progression: a longitudinal study
title_sort association between uric acid lowering and renal function progression: a longitudinal study
publisher PeerJ Inc.
series PeerJ
issn 2167-8359
publishDate 2021-03-01
description Background This study aimed to explore the association between uric acid lowering and renal function. Materials and Methods We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range of changes in serum uric acid with quartile 1 representing lower quarter. Renal function decline was defined as eGFR decreased more than 10% from baseline in 2016. Renal function improvement was defined as eGFR increased more than 10% from baseline in 2016. Cox regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI). Results In the adjusted Cox regression models, compared to quartile 4, quartile 1 (HR = 0.64, 95% CI [0.49–0.85]), quartile 2 (HR = 0.65, 95% CI [0.50–0.84]) and quartile 3 (HR = 0.75, 95% CI [0.58–0.96]) have reduced risk of renal function decline. An increasing hazard ratio of renal function improvement was shown in quartile 1 (HR = 2.27, 95% CI [1.45–3.57]) and quartile 2 (HR = 1.78, 95% CI [1.17–2.69]) compared with quartile 4. Conclusions Uric acid lowering is associated with changes in renal function. The management of serum uric acid should receive attention in clinical practice and is supposed to be part of the treatment of chronic kidney disease.
topic Uric acid lowering
Renal function
Chronic kidney disease
Population-based study
url https://peerj.com/articles/11073.pdf
work_keys_str_mv AT liyiliu associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT liliyou associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT kansun associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT fengli associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT yiqinqi associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT chaogangchen associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT chuanwang associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT guojuanlao associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT shengnengxue associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT juyingtang associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT nali associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT wantingfeng associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT chuanyang associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT mingtongxu associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT yanli associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT liyan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT mengren associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
AT diaozhulin associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy
_version_ 1724201895538458624